Behavioral functions of GABAA receptor subtypes - The zurich experience

Advances in Pharmacology

Volumn 72, Issue , 2015, Pages 37-51

  Crestani, Florence ^a   Rudolph, Uwe ^b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Benzodiazepines; GABAA receptor; Genetically modified mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ALCOHOL; ALPRAZOLAM; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ENFLURANE; ETOMIDATE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PENTETRAZOLE; PENTOBARBITAL; PROPOFOL; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; ZOLPIDEM;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; DEFENSIVE BEHAVIOR; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; FOREBRAIN; KNOCKOUT MOUSE; LOW DRUG DOSE; MEMORY; MICROARRAY ANALYSIS; MOUSE; MYOCLONUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATION CONTROL; RESPIRATION DEPRESSION; SEDATION; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BRAIN; HUMANS; MICE; POINT MUTATION; RECEPTORS, GABA-A;

EID: 84921315378     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2014.10.001     Document Type: Chapter

References (43)

1. A receptors: Classification on the basis of subunit structure and receptor function. Pharmacological Reviews 1998, 50:291-313.
2. A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 2009, 56:174-181.
3. A receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Letters 1998, 431(3):400-404.
4. 3H)diazepam binding. Proceedings of the National Academy of Sciences of the United States of America 1977, 74:3805-3809.
5. A receptor. Journal of Neuroscience 2002, 22:5572-5580.
6. A receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists. Neuropharmacology 2002, 43:679-684.
7. A receptors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8980-8985.
8. A-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neuroscience 1999, 2:833-839.
9. Crestani F., Löw K., Keist R., Mandelli M., Möhler H., Rudolph U. Molecular targets for the myorelaxant action of diazepam. Molecular Pharmacology 2001, 59:442-445.
10. Crestani F., Martin J.R., Möhler H., Rudolph U., Crestani F., Martin J.R., et al. Mechanism of action of the hypnotic zolpidem in vivo. British Journal of Pharmacology 2000, 131:1251-1254.
11. A receptors in mediating the anxiolytic effects of benzodiazepines. Journal of Neuroscience 2005, 25:10682-10688.
12. Earnheart J.C., Schweizer C., Crestani F., Iwasato T., Itohara S., Möhler H., et al. GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. Journal of Neuroscience 2007, 27:3845-3854.
13. A receptors: A target for the development of novel treatment strategies for CNS disorders. Pharmacology & Therapeutics 2012, 136:142-152.
14. Fritschy J.M., Benke D., Mertens S., Oertel W.H., Bachi T., Möhler H. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:6726-6730.
15. Günther U., Benson J., Benke D., Fritschy J.M., Reyes G., Knoflach F., et al. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:7749-7753.
16. Huerta P.T., Sun L.D., Wilson M.A., Tonegawa S. Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 2000, 25:473-480.
17. A receptor-specific expression profiling. Journal of Neurochemistry 2004, 88:1059-1067.
18. A receptor β3 subunit. FASEB Journal 2003, 17:250-252.
19. A receptors α4β2γ2 and α6β2γ2. Molecular Pharmacology 1996, 50:1253-1261.
20. Koester C., Rudolph U., Haenggi T., Papilloud A., Fritschy J.M., Crestani F. Dissecting the role of diazepam-sensitive γ-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat. Pharmacology, Biochemistry, and Behavior 2013, 103:541-549.
21. A receptor α1 subunit knockout mice. Journal of Pharmacology and Experimental Therapeutics 2002, 302:1037-1045.
22. A receptor α1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 2002, 43:685-694.
23. Kralic J.E., Sidler C., Parpan F., Homanics G.E., Morrow A.L., Fritschy J.M. Compensatory alteration of inhibitory synaptic circuits in cerebellum and thalamus of γ-aminobutyric acid type A receptor α1 subunit knockout mice. Journal of Comparative Neurology 2006, 495:408-421.
24. A receptors. European Journal of Pharmacology 2005, 516:23-27.
25. Löw K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
26. A receptors in mediating the respiratory changes associated with benzodiazepine sedation. British Journal of Pharmacology 2012, 166:339-348.
27. A receptor α1 subtype. Nature Neuroscience 2000, 3(6):587-592.
28. Möhler H., Okada T. Benzodiazepine receptor: Demonstration in the central nervous system. Science 1977, 198:849-851.
29. A receptor α5 subunits disrupts the memory for location of objects in mice. Genes, Brain, & Behavior 2010, 9:478-488.
30. Rudolph U., Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nature Reviews Neuroscience 2004, 5:709-720.
31. A receptor subtypes. Nature 1999, 401:796-800.
32. A receptor subtypes. Nature Reviews Drug Discovery 2011, 10:685-697.
33. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology & Toxicology 2004, 44:475-498.
34. A receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. Annual Review of Pharmacology & Toxicology 2014, 54:483-507.
35. Schoch P., Richards J.G., Haring P., Takacs B., Stahli C., Staehelin T., et al. Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature 1985, 314:168-171.
36. A receptor subtypes. Neuropharmacology 2012, 62:54-62.
37. A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo. European Journal of Neuroscience 2003, 18:2599-2604.
38. A receptors for the development of tolerance to the sedative action of diazepam in mice. Journal of Neuroscience 2004, 24:6785-6790.
39. A receptors is essential for benzodiazepine agonist binding. Journal of Biological Chemistry 1992, 267:1426-1429.
40. Zeller A., Arras M., Jurd R., Rudolph U. Identification of a molecular target mediating the general anesthetic actions of pentobarbital. Molecular Pharmacology 2007, 71:852-859.
41. A receptors to volatile and intravenous general anesthetic actions. BMC Pharmacology 2007, 7:2.
42. Zeller A., Arras M., Lazaris A., Jurd R., Rudolph U. Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB Journal 2005, 19:1677-1679.
43. Zeller A., Crestani F., Camenisch I., Iwasato T., Itohara S., Fritschy J.M., et al. Cortical glutamatergic neurons mediate the motor sedative action of diazepam. Molecular Pharmacology 2008, 73:282-291.